Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Operating Expenses | 909 | 1,333 | 1,050 | 1,170 | 1,292 |
| Operating Income | -909 | -1,333 | -1,050 | -1,170 | -1,292 |
| Other Income | 5 | 5 | 5 | 8 | 6 |
| Pre-tax Income | -904 | -1,329 | -1,045 | -1,162 | -1,287 |
| Net Income Continuous | -904 | -1,329 | -1,045 | -1,162 | -1,287 |
| Net Income | $-904 | $-1,329 | $-1,045 | $-1,162 | $-1,287 |
| EPS Basic Total Ops | -0.05 | -0.07 | -0.06 | -0.04 | -0.09 |
| EPS Basic Continuous Ops | -0.05 | -0.07 | -0.06 | -0.05 | -0.09 |
| EPS Diluted Total Ops | -0.05 | -0.07 | -0.06 | -0.04 | -0.09 |
| EPS Diluted Continuous Ops | -0.05 | -0.07 | -0.06 | -0.05 | -0.09 |
| EBITDA(a) | $-902 | $-1,327 | $-1,044 | $-1,163 | $-1,285 |